?Post-authorization safety study to check the potential association be
Post-authorization safety study to check the potential association between the safety
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Interferon beta-1a
Interferon alpha/beta receptor agonist
Who could take part
MS (type not specified)
Show the full criteria
Inclusion criteria
Inclusion: 1. El paciente tiene EM recidivante Exclusion: 1. EM primaria progresiva o EM secundaria progresiva sin recidivas superpuestas.
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Verificar la posible asociación entre parámetros farmacodinámicos y acontecimientos adversos en el escalado de dosis inicial del tratamiento
Papers
Loading reviews and guidelines…
Related trials
- An Observational Study to Learn About the Interferon-beta Exposure of
Running, not recruiting
Still running
- US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage a
Completed
No results found
- PROmyBETAappGame: a Study to Learn More About the Medication Usage & P
Completed
No results found
- EPID Multiple Sclerosis Pregnancy Study
Completed
No results found
- Comparison Study of PF530 and Betaferon in Healthy Subjects
Phase 1 · Completed
No results found
- Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterfer
Phase 1 · Completed
Paper found, not read
History
Started
Mar 2012